PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The P2X7 receptor, an adenosine triphosphate (ATP)-gated purinoreceptor, has emerged as one of the key players in neuroinflammatory processes. Therefore, developing a positron emission tomography (PET) tracer for imaging of P2X7 receptors in vivo presents a promising approach to diagnose, monitor, and study neuroinflammation in a variety of brain disorders. To fulfill the goal of developing a P2X7 PET ligand as a biomarker of neuroinflammation, [ 18 F]JNJ-64413739 has been recently disclosed. We evaluated [ 18 F]JNJ-64413739 in a rat model of neuroinflammation induced by an intracerebral injection of lipopolysaccharide (LPS). In vivo brain uptake was determined by PET imaging. Upregulation of neuroinflammatory biomarkers was determined by quantitative polymerase chain reaction (qPCR). Distribution of the tracer in the brain was determined by ex vivo autoradiography (ARG). The specificity of [ 18 F]JNJ-64413739 was confirmed by performing blocking experiments with the P2X7 antagonist JNJ-54175446. Brain regions of rats injected with LPS had a significantly increased uptake (34 % ± 3 % s.e.m., p = 0.036, t test, standardized uptake value measured over the entire scanning period) of [ 18 F]JNJ-64413739 relative to the corresponding brain regions of control animals injected with phosphate-buffered saline (PBS). The uptake in the contralateral regions and cerebellum was not significantly different between the groups of animals. The increase in uptake of [ 18 F]JNJ-64413739 at the LPS-injected site observed by PET imaging was concordant with ex vivo ARG, upregulation of neuroinflammatory biomarkers, and elevated P2X7 expression levels. While further work is needed to study [ 18 F]JNJ-64413739 in other types of neuroinflammation, the current results favorably characterize [ 18 F]JNJ-64413739 as a potential PET tracer of central neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374
Holmes, S. E., Hinz, R., Conen, S., Gregory, C. J., Matthews, J. C., Anton-Rodriguez, J. M., Gerhard, A., & Talbot, P. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.005 · Cited by 346
Neuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
The role of microglial P2X7: modulation of cell death and cytokine release
He, Y., Taylor, N., Fourgeaud, L., & Bhattacharya, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0904-8 · Cited by 194
Self-citationSuridjan, I., Pollock, B. G., Verhoeff, N. P. L. G., Voineskos, A. N., Chow, T., Rusjan, P. M., Lobaugh, N. J., Houle, S., Mulsant, B. H., & Mizrahi, R. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.1 · Cited by 132
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115
Self-citationMicroglial activation in Parkinson’s disease using [18F]-FEPPA
Ghadery, C., Koshimori, Y., Coakeley, S., Harris, M., Rusjan, P., Kim, J., Houle, S., & Strafella, A. P. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0778-1 · Cited by 113
Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment
Knezevic, D., & Mizrahi, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.007 · Cited by 97
Cerami, C., Iaccarino, L., & Perani, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050993 · Cited by 75
Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
Zhang, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0236-5 · Cited by 62
Research works printed but not linked: 55
- De Picker LJ, Morrens M, Chance SA, Boche D (2017) Microglia and brain plasticity in acute psychosis and schizophrenia illness course: a meta-review. Front Psych 8:238 · DOI · Paper page
- Skaper SD, Facci L, Zusso M, Giusti P (2018) An inflammation-centric view of neurological disease: beyond the neuron. Front Cell Neurosci 12(72) · DOI · Paper page
- Banjara M, Ghosh C (2017) Sterile neuroinflammation and strategies for therapeutic intervention. Int J Inflam 2017:8385961 · DOI · Paper page
- Göbel K, Ruck T, Meuth SG (2018) Cytokine signaling in multiple sclerosis: lost in translation. Mult Scler J 24:432–439 · DOI
- Bauer ME, Teixeira AL (2018) Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 2018; 1–11 · DOI · Paper page
- Scolding N (2014) Recognising and diagnosing inflammatory brain disease. J Neurol Neurosurg Psychiatry 85:e3 · doi:10.1136/jnnp-2014-308883.12
- Janssen B, Vugts JD, Windhorst DA, Mach HR (2018) PET imaging of microglial activation—beyond targeting TSPO. Molecules 23:607 · DOI · Paper page
- Hortala L, Arnaud J, Roux P et al (2014) Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor. Bioorganic Med Chem Lett 24:283–287 · DOI
- Horti AG, Gao Y, Ravert HT et al (2010) Synthesis and biodistribution of [(11)C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB(2)). Bioorganic Med Chem 18:5202–5207 · DOI
- Moldovan R-P, Teodoro R, Gao Y, Deuther-Conrad W, Kranz M, Wang Y, Kuwabara H, Nakano M, Valentine H, Fischer S, Pomper MG, Wong DF, Dannals RF, Brust P, Horti AG (2016) Development of a high-affinity PET radioligand for imaging cannabinoid subtype 2 receptor. J Med Chem 59:7840–7855 · DOI
- Slavik R, Herde AM, Bieri D, Weber M, Schibli R, Krämer SD, Ametamey SM, Mu L (2015) Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. Eur J Med Chem 92:554–564 · DOI
- de Vries EFJ, Doorduin J, Dierckx RA, van Waarde A (2008) Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl Med Biol 35:35–42 · DOI
- Cao Q, Cai W, Li Z-B, Chen K, He L, Li HC, Hui M, Chen X (2007) PET imaging of acute and chronic inflammation in living mice. Eur J Nucl Med Mol Imaging 34:1832–1842 · DOI
- Wang L, Cheng R, Fujinaga M, Yang J, Zhang Y, Hatori A, Kumata K, Yang J, Vasdev N, du Y, Ran C, Zhang MR, Liang SH (2017) A facile radiolabeling of [18F]FDPA via spirocyclic iodonium ylides: preliminary PET imaging studies in preclinical models of neuroinflammation. J Med Chem 60:5222–5227 · DOI
- Airas L, Nylund M, Rissanen E (2018) Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography. Front Neurol 9:181 · DOI · Paper page
- Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, Bloomfield MAP, Bonoldi I, Kalk N, Turkheimer F, McGuire P, de Paola V, Howes OD (2016) Microglial activity in people at ultra high risk of psychosis and in schizophrenia; an [11C]PBR28 PET brain imaging study. Am J Psychiat 173:44–52 · DOI · Paper page
- Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y (2017) Depiction of microglial activation in aging and dementia: positron emission tomography with [11C]DPA713 versus [11C](R)PK11195. J Cereb Blood Flow Metab 37:877–889 · DOI · Paper page
- Selvaraj S, Bloomfield PS, Cao B, Veronese M, Turkheimer F, Howes OD (2018) Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: an [11C]PBR28 study. Schizophr Res 195:206–214 · DOI · Paper page
- Di Biase MA, Zalesky A, O'Keefe G et al (2017) PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry 7:e1225 · DOI · Paper page
- Hafizi S, Da Silva T, Gerritsen C et al (2017) Imaging microglial activation in individuals at clinical high risk for psychosis: an in vivo PET study with [18F]FEPPA. Neuropsychopharmacol 42:2474–2481 · DOI
- Narendran R, Frankle WG (2016) Comment on analyses and conclusions of “microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C]PBR28 PET brain imaging study”. Am J Psychiatry 173:536–537 · DOI
- Notter T, Coughlin JM, Gschwind T et al (2017) Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 23:323 · DOI · Paper page
- Notter T, Coughlin JM, Sawa A, Meyer U (2017) Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry 23:36 · DOI
- van der Doef TF, de Witte LD, ALm S et al (2016) In vivo (R)-[ 11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ Schizophr 2:16031 · DOI · Paper page
- Koshimori Y, Ko J-H, Mizrahi R, Rusjan P, Mabrouk R, Jacobs MF, Christopher L, Hamani C, Lang AE, Wilson AA, Houle S, Strafella AP (2015) Imaging striatal microglial activation in patients with Parkinson’s disease. PLoS One 10:e0138721 · DOI · Paper page
- Vivash L, O'Brien TJ (2016) Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med 57:165–168 · DOI · Paper page
- Kreisl WC, Henter ID, Innis RB (2018) Imaging translocator protein as a biomarker of neuroinflammation in dementia. In: Advances in pharmacology. Ed. Pasternak GW, Coyle JT. Academic Press, pp. 163–85 · DOI · Paper page
- Ottoy J, De Picker L, Verhaeghe J et al (2018) [18F]PBR111 PET imaging in healthy controls and schizophrenia: test – retest reproducibility and quantification of neuroinflammation. J Nucl Med 59:1267–1274 · DOI
- Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, Searle G, Goldstone AP, Brooks DJ, Nicholas RS, Trigg W, Gunn RN, Sharp DJ (2016) Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Eur J Nucl Med Mol Imaging 43:2201–2210 · DOI · Paper page
- Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, da Settimo F, Fujita M, Pike VW, Innis RB (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320–325 · DOI · Paper page
- Lagarde J, Sarazin M, Bottlaender M (2018) In vivo PET imaging of neuroinflammation in Alzheimer’s disease. J Neural Transm 125:847–867 · DOI
- Tronel C, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Dupont AC, Arlicot N (2017) Molecular targets for PET imaging of activated microglia: the current situation and future expectations. Int J Mol Sci 18:802 · DOI · Paper page
- Gatliff J, East DA, Singh A, Alvarez MS, Frison M, Matic I, Ferraina C, Sampson N, Turkheimer F, Campanella M (2017) A role for TSPO in mitochondrial Ca(2+) homeostasis and redox stress signaling. Cell Death Dis 8:e2896 · DOI · Paper page
- Guilarte TR, Loth MK, Guariglia SR (2016) TSPO finds NOX2 in microglia for redox homeostasis. Trends Pharmacol Sci 37:334–343 · DOI · Paper page
- Li F, Liu J, Liu N, Kuhn LA, Garavito RM, Ferguson-Miller S (2016) Translocator protein 18 kDa (TSPO): an old protein with new functions? Biochemistry 55:2821–2831 · DOI · Paper page
- Papadopoulos V, Fan J, Zirkin B (2017) Translocator protein (18 kDa): an update on its function in steroidogenesis. J Neuroendocrinol 30:e12500 · DOI
- Yasin N, Veenman L, Singh S, Azrad M, Bode J, Vainshtein A, Caballero B, Marek I, Gavish M (2017) Classical and novel TSPO ligands for the mitochondrial TSPO can modulate nuclear gene expression: implications for mitochondrial retrograde signaling. Int J Mol Sci 18:786 · DOI
- Fantoni ER, Dal Ben D, Falzoni S, di Virgilio F, Lovestone S, Gee A (2017) Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7. EJNMMI Res 7:31 · DOI · Paper page
- Territo PR, Meyer JA, Peters JS, Riley AA, McCarthy BP, Gao M, Wang M, Green MA, Zheng QH, Hutchins GD (2017) Characterization of (11)C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation. J Nucl Med 58:458–465 · DOI · Paper page
- Bhattacharya A, Wang Q, Ao H, Shoblock JR, Lord B, Aluisio L, Fraser I, Nepomuceno D, Neff RA, Welty N, Lovenberg TW, Bonaventure P, Wickenden AD, Letavic MA (2013) Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol 170:624–640 · DOI · Paper page
- Lord B, Aluisio L, Shoblock JR, Neff RA, Varlinskaya EI, Ceusters M, Lovenberg TW, Carruthers N, Bonaventure P, Letavic MA, Deak T, Drinkenburg W, Bhattacharya A (2014) Pharmacology of a novel central nervous system–penetrant P2X7 antagonist JNJ-42253432. J Pharmacol Exp Ther 351:628–641 · DOI
- Ory D, Celen S, Gijsbers R, van den Haute C, Postnov A, Koole M, Vandeputte C, Andres JI, Alcazar J, de Angelis M, Langlois X, Bhattacharya A, Schmidt M, Letavic MA, Vanduffel W, van Laere K, Verbruggen A, Debyser Z, Bormans G (2016) Preclinical evaluation of a P2X7 receptor-selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates. J Nucl Med 57:1436–1441 · DOI · Paper page
- Gao M, Wang M, Green MA, Hutchins GD, Zheng QH (2015) Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X(7) receptor. Bioorg Med Chem Lett 25:1965–1970 · DOI
- Janssen B, Vugts Danielle J, Funke U et al (2014) Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation. J Label Compd Radiopharm 57:509–516 · DOI · Paper page
- Gao M, Wang M, Glick-Wilson BE, Meyer JA, Peters JS, Territo PR, Green MA, Hutchins GD, Zarrinmayeh H, Zheng QH (2018) Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601. Bioorganic Med Chem Lett 28:1603–1609 · DOI
- Janssen B, Vugts DJ, Wilkinson SM, Ory D, Chalon S, Hoozemans JJM, Schuit RC, Beaino W, Kooijman EJM, van den Hoek J, Chishty M, Doméné A, van der Perren A, Villa A, Maggi A, Molenaar GT, Funke U, Shevchenko RV, Baekelandt V, Bormans G, Lammertsma AA, Kassiou M, Windhorst AD (2018) Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation. Sci Rep 8:6580 · DOI
- Koole M, Schmidt M, Hijzen A et al (2018) 18F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability and occupancy of the P2X7 antagonist JNJ-54175446. J Nucl Med 118:216747
- Facci L, Barbierato M, Marinelli C et al (2014) Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1β release. Sci Rep 4:6824 · DOI · Paper page
- Spildrejorde M, Curtis SJ, Curtis BL, Sluyter R (2014) Extracellular adenosine 5′-triphosphate and lipopolysaccharide induce interleukin-1beta release in canine blood. Vet Immunol Immunopathol 157:105–110 · doi:10.1016/j.vetimm.2013.11.002
- Wynick C, Petes C, Tigert A, Gee K (2016) Lipopolysaccharide-mediated induction of concurrent IL-1β and IL-23 expression in THP-1 cells exhibits differential requirements for caspase-1 and cathepsin B activity. J Interf Cytokine Res 36:477–487 · DOI
- Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, van Laere K, Bormans G, Casteels C (2016) Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F]DPA-714 PET. Eur J Nucl Med Mol Imaging 43:163–172 · DOI
- Letavic MA, Savall BM, Allison BD, Aluisio L, Andres JI, de Angelis M, Ao H, Beauchamp DA, Bonaventure P, Bryant S, Carruthers NI, Ceusters M, Coe KJ, Dvorak CA, Fraser IC, Gelin CF, Koudriakova T, Liang J, Lord B, Lovenberg TW, Otieno MA, Schoetens F, Swanson DM, Wang Q, Wickenden AD, Bhattacharya A (2017) 4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate. J Med Chem 60:4559–4572 · DOI · Paper page
- Han J, Liu H, Liu C, Jin H, Perlmutter JS, Egan TM, Tu Z (2017) Pharmacologic characterizations of a P2X7R-specific radioligand, [(11)C]GSK1482160 for neuroinflammatory response. Nucl Med Commun 38:372–382 · DOI
- Beaino W, Janssen B, Kooij G, van der Pol SMA, van het Hof B, van Horssen J, Windhorst AD, de Vries HE (2017) Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis. J Neuroinflamm 14:259 · DOI · Paper page
- Hansson E (2006) Could chronic pain and spread of pain sensation be induced and maintained by glial activation? Acta Physiol 187:321–327 · DOI · Paper page
Cited by
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer, J. H., Cervenka, S., Kim, M.-J., Kreisl, W. C., Henter, I. D., & Innis, R. B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30255-8 · Cited by 270
Cellular sources of TSPO expression in healthy and diseased brain
Nutma, E., Ceyzériat, K., Amor, S., Tsartsalis, S., Millet, P., Owen, D. R., Papadopoulos, V., & Tournier, B. B. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05166-2 · Cited by 192
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162
Inflamed brain: Targeting immune changes and inflammation for treatment of depression
Sakamoto, S., Zhu, X., Hasegawa, Y., Karma, S., Obayashi, M., Alway, E., & Kamiya, A. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13286 · Cited by 51
Crabbé, M., Van der Perren, A., Bollaerts, I., Kounelis, S., Baekelandt, V., Bormans, G., Casteels, C., Moons, L., & Van Laere, K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00799 · Cited by 49
Metadata
- Authors
- Berdyyeva, T., Xia, C., Taylor, N., He, Y., Chen, G., Huang, C., Zhang, W., Kolb, H., Letavic, M., Bhattacharya, A., & Szardenings, A. K.
- Venue
- Molecular Imaging and Biology
- Published
- 2019-01-10
- Volume
- 21
- Issue
- 5
- Pages
- 871-878
- ISSN
- 1536-1632 (ISSN-L)
- 1860-2002
- OpenAlex
- W2910358403
- Cited by
- 60
- References
- 10
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation. https://app.cochat.ai/papers/10.1007/s11307-018-01313-2
- The paper
- Berdyyeva, T., Xia, C., Taylor, N., He, Y., Chen, G., Huang, C., Zhang, W., Kolb, H., Letavic, M., Bhattacharya, A., & Szardenings, A. K. (2019). PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-018-01313-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.